Emedgene, an Illumina Company

Emedgene, an Illumina Company, develops software focused on germline variant interpretation for genomic analysis. Its main product, Emedgene software, enhances the efficiency of processes such as variant interpretation, prioritization, curation, and research report generation.

The company specializes in genomic software solutions that address inherited genetic variations relevant to clinical and research applications. By integrating with Illumina's ecosystem of sequencing and bioinformatics tools, Emedgene aims to streamline genomic data workflows, ultimately supporting researchers and clinicians in hereditary disease studies and personalized medicine.